US5565215A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Biodegradable injectable particles for imaging
Assignee: Massachusetts Institute of Technology
•
Filing: 1994-03-18
•
Granted: 1996-10-15
•
Expires: 2014-03-18
Abstract
Abstract Injectable nanoparticles or microparticles are provided that are not rapidly cleared from the blood stream by the macrophages of the reticuloendothelial system, and that can be modified as necessary to achieve variable release rates or to target specific cells or organs as desired. The terminal hydroxyl group of the poly(alkylene glycol) can be used to covalently attach onto the surface of the injectable particles biologically active molecules, including antibodies targeted to specific cells or organs, or molecules affecting the charge, lipophilicity or hydrophilicity of the particle. The surface of the particle can also be modified by attaching biodegradable polymers of the same structure as those forming the core of the injectable particles. The injectable particles include magnetic particles or radioopaque materials for diagnostic imaging.
Inventors
- 👤 Ruxandra Gref
- 👤 Yoshiharu Minamitake
- 👤 Robert S. Langer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 07:56
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/513; A61K9/5146; A61K9/5153; A61K47/00; A61K47/50; A61K47/69; A61K47/6921; A61K47/6927; A61K47/6929; A61K47/6931; A61K47/6935; A61K49/00; A61K49/22; A61K49/222; A61K49/223; A61K51/00; A61K51/12; A61K51/1241; A61K51/1244; A61K51/1251; A61K9/0012; A61K9/0019; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1635; A61K9/1641; A61K9/1647; A61K9/5138; B; B82; B82Y; B82Y5/00; C; C08; C08G; C08G63/00; C08G63/66; C08G63/664; C08G81/00; C08J; C08J3/00; C08J3/12; C08J3/14; A61K2123/00; C08J2300/00; C08J2300/16; C08J2367/00; C08J2367/04; C08J2371/00; C08J2371/02; Y; Y10; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984; Y10T428/2985; Y10T428/2989; Y10T428/2991
Claims Analysis
Total Claims: 33
Claim 1
Independent Claim
68 words
A microparticle or nanoparticle comprising an imaging agent and a copolymer consisting essentially of poly(alkylene glycol) and a polymer selected from the group consisting of polyanhydride, polyhydroxybutyric acid, polyorthoesters, polysiloxanes, polycaprolactone, poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid) and copolymers prepared from the monomers of these polymers, wherein an effective amount of the poly(alkylene glycol) is on the surface of the particles to decrease uptake by the reticuloendothelial system.
Claim 2
Dependent Claim
68 words
A microparticle or nanoparticle comprising an imaging agent and a copolymer consisting essentially of poly(alkylene glycol) and a polymer selected from the group consisting of polyanhydride, polyhydroxybutyric acid, polyorthoesters, polysiloxanes, polycaprolactone, poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid) and copolymers prepared from the monomers of these polymers, wherein an effective amount of the poly(alkylene glycol) is on the surface of the particles to decrease uptake by the reticuloendothelial system.
Claim 3
Dependent Claim
67 words
The nanoparticles or microparticles of claim 1 comprising molecules covalently bound to the surface of the particle via the terminal hydroxyl group of the poly(alkylene glycol), wherein the molecules are selected from the group consisting of molecules to be delivered to a site which have biological activity, molecules which can be detected, targeting molecules, and molecules affecting the charge, lipophilicity or hydrophilicity of the nanoparticles or microparticles.
Claim 4
Dependent Claim
26 words
The nanoparticles or microparticles of claim 2, wherein the targeting molecule is selected from the group consisting of compounds specifically reactive with a cell surface component.
Claim 5
Dependent Claim
21 words
The nanoparticles or microparticles of claim 3 wherein the molecule is selected from the group consisting of antibodies and antibody fragments.
Claim 6
Dependent Claim
18 words
The nanoparticles or microparticles of claim 3, wherein the poly(alkylene glycol) is covalently bound to the targeting molecules.
Claim 7
Dependent Claim
15 words
The nanoparticles or microparticles of claim 1 wherein the diameter is less than one micron.
Claim 8
Dependent Claim
15 words
The nanoparticles or microparticles of claim 1 wherein the diameter between one and 1000 microns.
Claim 9
Dependent Claim
30 words
The nanoparticles or microparticles of claim 1 wherein the imaging agent is selected from the group of agents detectable by x-ray, fluorescence, magnetic resonance imaging, radioactivity, ultrasound, CT and PET.
Claim 10
Dependent Claim
14 words
The nanoparticles or microparticles of claim 1, wherein the poly(alkylene glycol) is poly(ethylene glycol).
Claim 11
Dependent Claim
39 words
The nanoparticles or microparticles of claim 1 wherein the copolymer is a copolymer of a polymer selected from the group consisting of poly(lactic-co-glycolic acid), poly(lactic acid), and poly(glycolic acid), the copolymer having two or more moieties of poly(alkylene glycol).
Claim 12
Dependent Claim
36 words
The nanoparticles or microparticles of claim 1 wherein the copolymer is a copolymer of a polymer selected from the group consisting of poly(lactic-co-glycolic acid), poly(lactic acid), and poly(glycolic acid) with poly(alkylene glycol), blended with poly(lactic-co-glycolic acid).
Claim 13
Dependent Claim
34 words
The nanoparticles or microparticles of claim 1 wherein the surface of the nanoparticles or microparticles is modified by attaching biodegradable polymers of the same structure as those forming the core of the injectable particles.
Claim 14
Independent Claim
84 words
A method for making nanoparticles or microparticle comprising combining together imaging agent and a copolymer consisting essentially of poly(alkylene glycol) and a polymer selected from the group consisting of polyanhydride, polyhydroxybutyric acid, polyorthoesters other than the homopolymer of lactic acid, polysiloxanes, polycaprolactone, poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid) and copolymers prepared from the monomers of these polymers, and forming nanoparticles or microparticles, wherein an effective amount of the poly(alkylene glycol) is on the surface of the particles to decrease uptake by the reticuloendothelial system.
Claim 15
Independent Claim
84 words
A method for making nanoparticles or microparticle comprising combining together imaging agent and a copolymer consisting essentially of poly(alkylene glycol) and a polymer selected from the group consisting of polyanhydride, polyhydroxybutyric acid, polyorthoesters other than the homopolymer of lactic acid, polysiloxanes, polycaprolactone, poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid) and copolymers prepared from the monomers of these polymers, and forming nanoparticles or microparticles, wherein an effective amount of the poly(alkylene glycol) is on the surface of the particles to decrease uptake by the reticuloendothelial system.
Claim 16
Dependent Claim
13 words
The method of claim 13 wherein the imaging agent is detectable by ultrasound.
Claim 17
Dependent Claim
56 words
The method of claim 13 further comprising covalently binding to the surface of the nanoparticles or microparticles via the terminal hydroxyl group of the poly(alkylene glycol) molecules selected from the group consisting of molecules which have biological activity, molecules which can be detected, targeting molecules, and molecules affecting the charge, lipophilicity or hydrophilicity of the particle.
Claim 18
Dependent Claim
44 words
The method of claim 15 further comprising targeting the nanoparticles or microparticles for delivery to a specific cell type by attaching to the surface of the particle a targeting molecule selected from the group consisting of compounds specifically reactive with a cell surface component.
Claim 19
Dependent Claim
26 words
The method of claim 13 wherein the imaging agent is selected from the group of imaging agents detectable by x-ray, fluorescence, magnetic resonance imaging and radioactivity.
Claim 20
Dependent Claim
37 words
The method of claim 13 wherein the copolymer is a copolymer of a polymer selected from the group consisting of poly(lactic-co-glycolic acid), poly(lactic acid), and poly(glycolic acid), the copolymer having two or more moieties of poly(alkylene glycol).
Claim 21
Dependent Claim
34 words
The method of claim 13 wherein the copolymer is a copolymer of a polymer selected from the group consisting of poly(lactic-co-glycolic acid), poly(lactic acid), and poly(glycolic acid) with poly(alkylene glycol), blended with poly(lactic-co-glycolic acid).
Claim 22
Dependent Claim
32 words
The method of claim 13 wherein the surface of the nanoparticles or microparticles is modified by attaching biodegradable polymers of the same structure as those forming the core of the injectable particles.
Claim 23
Independent Claim
81 words
A method for imaging a region in a patient comprising administering to the patient nanoparticles or microparticles comprising an imaging agent and a copolymer consisting essentially of poly(alkylene glycol) and a polymer selected from the group consisting of polyanhydride, polyhydroxybutyric acid, polyorthoesters, polysiloxanes, polycaprolactone, poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid) and copolymers prepared from the monomers of these polymers, wherein an effective amount of the poly(alkylene glycol) is on the surface of the particles to decrease uptake by the reticuloendothelial system.
Claim 24
Independent Claim
81 words
A method for imaging a region in a patient comprising administering to the patient nanoparticles or microparticles comprising an imaging agent and a copolymer consisting essentially of poly(alkylene glycol) and a polymer selected from the group consisting of polyanhydride, polyhydroxybutyric acid, polyorthoesters, polysiloxanes, polycaprolactone, poly(lactic acid), poly(glycolic acid), poly(lactic-co-glycolic acid) and copolymers prepared from the monomers of these polymers, wherein an effective amount of the poly(alkylene glycol) is on the surface of the particles to decrease uptake by the reticuloendothelial system.
Claim 25
Dependent Claim
28 words
The method of claim 21 wherein the imaging agent is selected from the group of agents detectable by x-ray, fluorescence, magnetic resonance imaging, radioactivity, ultrasound, PET, and CT.
Claim 26
Dependent Claim
22 words
The method of claim 22 wherein the imaging agent is a gas selected from the group consisting of air, oxygen and perfluorocarbon.
Claim 27
Dependent Claim
24 words
The nanoparticles or microparticles of claim 8 wherein the imaging agent is a gas present in an effective amount to be detected by ultrasound.
Claim 28
Dependent Claim
21 words
The nanoparticles or microparticles of claim 24 wherein the gas is selected from the group consisting of air, oxygen and perfluorocarbon.
Claim 29
Dependent Claim
12 words
The nanoparticles or microparticles of claim 25 wherein the gas is perfluorocarbon.
Claim 30
Dependent Claim
22 words
The method of claim 17 wherein the imaging agent is a gas present in an effective amount to be detected by ultrasound.
Claim 31
Dependent Claim
19 words
The method of claim 27 wherein the gas is selected from the group consisting of air, oxygen and perfluorocarbon.
Claim 32
Dependent Claim
10 words
The method of claim 28 wherein the gas is perfluorocarbon.
Claim 33
Dependent Claim
10 words
The method of claim 23 wherein the gas is perfluorocarbon.
References Cited (Backward Citations)
EP0092918A2
Cited
US4801739A
Cited
EP0166596A2
Cited
US4904479A
Cited
EP0295055A2
Cited
EP0552802A2
Cited
WO1994002122A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-10-15 | 2000-04-15 | 2000-10-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-10-15 | 2004-04-15 | 2004-10-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-10-15 | 2008-04-15 | 2008-10-15 | $7700.00 | Window Closed / Lapsed |